<VariationArchive VariationID="619001" VariationName="NM_014231.5(VAMP1):c.340del (p.Ile114fs)" VariationType="Deletion" Accession="VCV000619001" Version="13" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-07" DateCreated="2019-02-25" MostRecentSubmission="2024-07-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="610399" VariationID="619001">
      <GeneList>
        <Gene Symbol="TAPBPL" FullName="TAP binding protein like" GeneID="55080" HGNC_ID="HGNC:30683" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6451649" stop="6472006" display_start="6451649" display_stop="6472006" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6561176" stop="6571487" display_start="6561176" display_stop="6571487" Strand="+" />
          </Location>
          <OMIM>607081</OMIM>
        </Gene>
        <Gene Symbol="VAMP1" FullName="vesicle associated membrane protein 1" GeneID="6843" HGNC_ID="HGNC:12642" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6462237" stop="6470677" display_start="6462237" display_stop="6470677" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6571402" stop="6579842" display_start="6571402" display_stop="6579842" Strand="-" />
          </Location>
          <OMIM>185880</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014231.5(VAMP1):c.340del (p.Ile114fs)</Name>
      <CanonicalSPDI>NC_000012.12:6464889:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6464890" stop="6464890" display_start="6464890" display_stop="6464890" variantLength="1" positionVCF="6464889" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6574056" stop="6574056" display_start="6574056" display_stop="6574056" variantLength="1" positionVCF="6574055" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R114fs</ProteinChange>
      <ProteinChange>I114fs</ProteinChange>
      <ProteinChange>S114fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6574057del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6574057del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6464891del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6464891del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042188.2" sequenceAccession="NG_042188" sequenceVersion="2" change="g.11010del">
            <Expression>NG_042188.2:g.11010del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001297438.2" sequenceAccession="NM_001297438" sequenceVersion="2" change="c.340del">
            <Expression>NM_001297438.2:c.340del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001284367.1" sequenceAccession="NP_001284367" sequenceVersion="1" change="p.Arg114fs">
            <Expression>NP_001284367.1:p.Arg114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014231.5" sequenceAccession="NM_014231" sequenceVersion="5" change="c.340del" MANESelect="true">
            <Expression>NM_014231.5:c.340del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055046.1" sequenceAccession="NP_055046" sequenceVersion="1" change="p.Ile114fs">
            <Expression>NP_055046.1:p.Ile114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016830.4" sequenceAccession="NM_016830" sequenceVersion="4" change="c.340del">
            <Expression>NM_016830.4:c.340del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_058439.1" sequenceAccession="NP_058439" sequenceVersion="1" change="p.Arg114fs">
            <Expression>NP_058439.1:p.Arg114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199245.3" sequenceAccession="NM_199245" sequenceVersion="3" change="c.340del">
            <Expression>NM_199245.3:c.340del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_954740.1" sequenceAccession="NP_954740" sequenceVersion="1" change="p.Ser114fs">
            <Expression>NP_954740.1:p.Ser114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_123717.2" sequenceAccession="NR_123717" sequenceVersion="2" change="n.359del">
            <Expression>NR_123717.2:n.359del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014231.3" sequenceAccession="NM_014231" sequenceVersion="3" change="c.340del">
            <Expression>NM_014231.3:c.340del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014231.5" sequenceAccession="NM_014231" sequenceVersion="5" change="c.340delA" MANESelect="true">
            <Expression>NM_014231.5:c.340delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="185880.0002" DB="OMIM" />
        <XRef Type="rs" ID="746220436" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014231.5(VAMP1):c.340del (p.Ile114fs) AND Myasthenic syndrome, congenital, 25, presynaptic" Accession="RCV000757907" Version="4">
        <ClassifiedConditionList TraitSetID="46409">
          <ClassifiedCondition DB="MedGen" ID="C5193027">Myasthenic syndrome, congenital, 25, presynaptic</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-30" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014231.5(VAMP1):c.340del (p.Ile114fs) AND not provided" Accession="RCV001549899" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014231.5(VAMP1):c.340del (p.Ile114fs) AND Spastic paraplegia" Accession="RCV001855899" Version="3">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-27" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014231.5(VAMP1):c.340del (p.Ile114fs) AND Spastic ataxia 1" Accession="RCV002279727" Version="2">
        <ClassifiedConditionList TraitSetID="6859">
          <ClassifiedCondition DB="MedGen" ID="C1970107">Spastic ataxia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014231.5(VAMP1):c.340del (p.Ile114fs) AND VAMP1-related disorder" Accession="RCV004579562" Version="2">
        <ClassifiedConditionList TraitSetID="91514">
          <ClassifiedCondition>VAMP1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-04" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2019-02-25" MostRecentSubmission="2024-07-07">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28168212</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="91514" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="72182" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">VAMP1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VAMP1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VAMP1-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="46409" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41409" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myasthenic syndrome, congenital, 25</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myasthenic syndrome, congenital, 25, presynaptic</ElementValue>
                <XRef ID="MONDO:0032675" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMS25</ElementValue>
                <XRef Type="MIM" ID="618323" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16341" />
                <XRef ID="16341" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5193027" DB="MedGen" />
              <XRef ID="MONDO:0032675" DB="MONDO" />
              <XRef Type="MIM" ID="618323" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6859" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ataxia, spastic, 1, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Spastic ataxia 1</ElementValue>
                <XRef ID="MONDO:0007164" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPAX1</ElementValue>
                <XRef Type="MIM" ID="108600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17206" />
                <XRef ID="17206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <XRef ID="251282" DB="Orphanet" />
              <XRef ID="C1970107" DB="MedGen" />
              <XRef ID="MONDO:0007164" DB="MONDO" />
              <XRef Type="MIM" ID="108600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1735337" SubmissionDate="2019-04-09" DateLastUpdated="2019-04-12" DateCreated="2019-02-25">
        <ClinVarSubmissionID localKey="185880.0002_MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC" title="VAMP1, 1-BP DEL, 340A_MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC" />
        <ClinVarAccession Accession="SCV000886417" DateUpdated="2019-04-12" DateCreated="2019-02-25" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Brazilian girl, born of consanguineous unaffected parents, with presynaptic congenital myasthenic syndrome-25 (CMS25; 618323), Shen et al. (2017) identified a homozygous 1-bp deletion (c.340delA) in the VAMP1 gene, predicted to result in frameshifts and elongation of the protein: Ile114SerfsTer72 for isoform A (c.340delA, NM_014231.4), and Ser114ValfsTer34 for isoform D (c.340delA, NM_199245.2). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. It was found once in the heterozygous state in the ExAC database (1 in 11,574 Latino alleles). Expression of the mutation in HEK293 cells showed that it caused decreased levels of mutant A isoform (15% of normal) and the mutant D isoform (65% of normal). Transfection of the mutant VAMP1 isoforms into chromaffin cells resulted in significantly decreased depolarization-evoked exocytosis of catecholamine-containing vesicles (2 to 12%) compared to controls. These findings were consistent with a loss of function.</Attribute>
              <Citation>
                <ID Source="PubMed">28168212</ID>
              </Citation>
              <XRef DB="OMIM" ID="618323" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VAMP1" />
          </GeneList>
          <Name>VAMP1, 1-BP DEL, 340A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 340A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="185880.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5021729" SubmissionDate="2022-08-25" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="NVEM2985|MedGen:C1970107" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002567978" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28168212</ID>
          </Citation>
          <Comment>The c.340del;p.(Ile114Serfs*72) is a null frameshift variant (NMD) in the VAMP1 gene without sufficient information about prediction of nonsense mediated mRNA decay (NMD); it is present in a relevant exon to the transcript, and disrupts &lt; 10% of the protein product – PVS1_moderate. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant(ClinVar ID: 619001; PMID: 28168212) - PS4_supporting. The variant is present at low allele frequencies population databases (rs746220436 – gnomAD 0.0001314%; ABraOM no frequency - https://abraom.ib.usp.br/) -PM2_supporting.The p.(Ile114Serfs*72) was detected in trans with a pathogenic variant (PMID:28168212) - PM3. In summary, the currently available evidence indicates that the variant is likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VAMP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_014231.5:exon 4</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="746220436" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014231.5:c.340del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1970107" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11921719</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7114323" SubmissionDate="2023-03-01" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="974826c032b2aa8b286bdf524a1dfc77" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003806887" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 moderated, PS3 supporting, PS4 supporting, PM2 moderated, PM3 moderated</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <Description>Paired-end whole-genome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003560" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003236" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VAMP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014231.5:c.340del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618323" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12925816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3479690" SubmissionDate="2023-08-02" DateLastUpdated="2023-08-05" DateCreated="2021-08-07">
        <ClinVarSubmissionID localKey="GDXSV:281877" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001770135" DateUpdated="2023-08-05" DateCreated="2021-08-07" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a damaging effect with inhibition of depolarization-evoked exocytosis (Shen et al., 2017); Frameshift variant predicted to result in protein truncation as the last 5 amino acids are replaced with 71 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 28168212, 32616363)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VAMP1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1119542</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014231.3:c.340del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_208_20230802054202</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_20_20210805063641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4314514" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="2842314|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002287785" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28168212</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28168212</ID>
          </Citation>
          <Comment>In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that this frameshift affects VAMP1 function (PMID: 28168212). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 619001). This frameshift has been observed in individuals with clinical features of autosomal recessive VAMP1-related conditions (PMID: 28168212; Invitae). This variant is present in population databases (rs746220436, gnomAD 0.006%). This sequence change results in a frameshift in the VAMP1 gene (p.Ile114Serfs*72). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 5 amino acid(s) of the VAMP1 protein and extend the protein by 66 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VAMP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.6574056del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9833022" SubmissionDate="2024-06-29" DateLastUpdated="2024-07-07" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NM_014231.5:c.340delA|VAMP1-Related Disorders" />
        <ClinVarAccession Accession="SCV005062118" DateUpdated="2024-07-07" DateCreated="2024-06-29" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28168212</ID>
          </Citation>
          <Comment>Variant summary: VAMP1 c.340delA (p.Ile114SerfsX72) causes a frameshift which results in an extension of the protein by 66 amino acids. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8e-06 in 251340 control chromosomes. c.340delA has been reported in the literature in individuals affected with VAMP1-Related Disorders (Shen_2019). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in decreased expression and reduced depolarization-evoked exocytosis (Shen_2019). The following publication have been ascertained in the context of this evaluation (PMID: 28168212). ClinVar contains an entry for this variant (Variation ID: 619001). Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VAMP1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014231.5:c.340delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VAMP1-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-03.anno.csv</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7114323" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003560" MappingRef="HP">
        <MedGen CUI="C0026850" Name="Muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1735337" TraitType="Disease" MappingType="Name" MappingValue="MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC" MappingRef="Preferred">
        <MedGen CUI="C5193027" Name="Myasthenic syndrome, congenital, 25, presynaptic" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114323" TraitType="Disease" MappingType="XRef" MappingValue="618323" MappingRef="OMIM">
        <MedGen CUI="C5193027" Name="Myasthenic syndrome, congenital, 25, presynaptic" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3479690" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9833022" TraitType="Disease" MappingType="Name" MappingValue="VAMP1-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="VAMP1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4314514" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114323" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003236" MappingRef="HP">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5021729" TraitType="Disease" MappingType="XRef" MappingValue="C1970107" MappingRef="MedGen">
        <MedGen CUI="C1970107" Name="Spastic ataxia 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

